Advertisement

Topics

Parnell Pharmaceuticals, Inc. Company Profile

23:47 EDT 20th September 2018 | BioPortfolio

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity. Employing a proprietary and patented technology, Parnell Pharmaceuticals’ products contain Yerba Santa, which containts natural mucopolysaccharides and glycoproteins.The yerba santa plant, native to the foothills of the Pacific Northwest, has been used as an herbal remedy by many Native American tribes for centuries. Parnell Pharmaceuticals holds five patents for its yerba santa extract.These naturally occurring compounds mimic the glycoproteins found in human saliva and mucus. In formulation with other ingredients, these products closely resemble the consistency and pH of actual human saliva and mucus and help to protect the mouth, tongue, gums, teeth, throat, and nasal passages as well as providing vaginal mucoprotection.

Location

1525 Francisco Blvd
San Rafael
California
94901
United States of America

Contact

Phone: 415-256-1800
Fax: 415-256-8099
Email: mailman@parnellpharm.com


News Articles [320 Associated News Articles listed on BioPortfolio]

Parnell Pharmaceuticals Holdings Ltd.: Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management

SYDNEY, AUSTRALIA / ACCESSWIRE / July 31, 2018 / Parnell Pharmaceuticals Holdings Ltd. (OTC PINK: PARNF) ("Parnell" or the "Company"), a fully integrated pharmaceutical company focused on developin...

Parnell Pharmaceuticals Holdings Ltd.: Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018

Parnell Delivers 32% Revenue Growth And A $4.0 Million Improvement In EBITDA In The First Six Months Of 2018 Compared To The Same Period In 2017, Returns To Profitability For The First Time Post-IP...

Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma

Aridis Pharmaceuticals has raised $26m through an initial public offering of two million shares of its common stock priced at $13...Read More... The post Deals and M&As this week: Aridis Pharmac...

GW Pharmaceuticals plc: GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology

VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescr...

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement for the development and commercializ...

Telix Pharmaceuticals Limited: Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership

MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company focused on ...

Nuvo Pharmaceuticals to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

NewsUpon closing of the Proposed Transaction, Nuvo would pay Aralez $110 million in cash,

Newly Merged Amneal Pharmaceuticals to Push into the Biosimilar Space

Earlier this week Amneal Pharmaceuticals and Impax Laboratories completed their business merger, forming the new Amneal Pharmaceuticals. The combined companies are now the fifth largest generics busin...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [144 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [223 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1329 Associated Companies listed on BioPortfolio]

Parnell Pharmaceuticals, Inc.

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity. Employing a proprietary and patented te...

Parnell Pharmaceuticals

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity, thereby improving the quality of life o...

Parnell Pharmacy Ltd

The Parnell Pharmacy was founded on 4 simple principles:You are always right… it's just that simple when it comes to customer service! You deserve the best value… we must save you money to...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Parnell Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Parnell Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Parnell Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Parnell Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Parnell Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Parnell Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Dentistry
Dentistry is the study, management and treatment of diseases and conditions affecting the mouth, jaw, teeth and their supporting tissues (Oxford Medical Dictionary) The work of a dentist ranges from regular patient check-up to orthodontics and surgery....


Corporate Database Quicklinks



Searches Linking to this Company Record